Please assess the completion status of the following clinical trial:

Trial Title: Role Of Angiogenic Factors In The Development Of Hepatorenal Syndrome

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Sign informed consent~* Subjects who present for Liver Transplantation~* Subjects who present for Hepatic resection~* Subjects with Non-Surgical Liver Disease~Exclusion Criteria:~* Absence of Liver Disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: OTHER): 50 surgical subjects undergoing either liver transplantation or hepatic resection
- 2 (Type: OTHER): 50 Subjects with Liver disease who are are not surgical candidates

Based on this trial design, predict the completion outcome and termination type (if applicable).